ADIPOTIDE (5mg)

Adipotide is an experimental peptide that promotes fat loss by targeting blood vessels feeding fat cells, potentially improving metabolic health and preserving muscle mass.

Mechanism of Action

Adipotide, also known as FTPP (Fat-Targeted Proapoptotic Peptide), works through a vascular-targeted mechanism rather than hormonal or metabolic pathways. It selectively binds to prohibitin, a protein expressed on the endothelial cells of blood vessels supplying white adipose tissue. Once bound, it triggers apoptosis in these blood vessels, cutting off nutrients and oxygen to fat cells, which then die and are metabolized naturally Muscle and Brawn+2. This process is highly selective, sparing other tissues and muscle from damage cellpeptides.com.

Potential Benefits

1. Targeted Fat Loss: Preclinical studies in obese rhesus monkeys demonstrated significant reductions in visceral and abdominal fat, which is linked to cardiovascular disease and type 2 diabetes Muscle and Brawn+1.
2. Improved Metabolic Health: Adipotide treatment improved insulin sensitivity in animal models, suggesting potential benefits for glucose regulation and metabolic function Muscle and Brawn+1.
3. Muscle Preservation: Unlike traditional weight-loss methods that may cause muscle loss, Adipotide selectively targets fat tissue, helping maintain lean muscle mass during fat reduction cellpeptides.com.
4. Reduction of Fatty Acid Production: By eliminating white adipose tissue, Adipotide may decrease the body’s production of fatty acids, contributing to overall weight management thepeptidereport.com.
5. Potential for Obesity-Related Risk Reduction: By reducing visceral fat, Adipotide could theoretically lower the risk of type 2 diabetes, cardiovascular disease, and metabolic syndrome cellpeptides.com.

Limitations and Safety

Adipotide remains experimental and is NOT approved for human use. Preclinical studies showed promising results, but development was halted due to kidney toxicity concerns in animal models peptidedeck.com+1. Its safety, optimal dosing, and long-term effects in humans are unknown, and it should only be considered within controlled research settings.

Summary

Adipotide represents a novel approach to fat loss by targeting the vascular system of adipose tissue. Its benefits include selective fat reduction, improved insulin sensitivity, and muscle preservation, making it a unique candidate in obesity research. However, human studies are lacking, and safety concerns remain a major limitation Muscle and Brawn+2.